GRAIL, Inc. (GRAL) intrinsic value & 10-year financials

GRAIL, Inc. (GRAL) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 4 fiscal years revenue grew 25.7% a year to $147.2M, with an average return on invested capital of -52.9%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$117.81
Market cap
$4.3B
Revenue (FY2025)
$147.2M
Revenue growth (4-yr CAGR)
25.7%
ROIC (10-yr avg)
-52.9%
Free cash flow (FY2025)
-$299.9M

GRAL 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $147.2M -$408.4M -$11.11 -$299.9M -382.0% -18.2%
FY2024 $125.6M -$2.0B -$63.54 -$582.4M -1743.0% -87.5%
FY2023 $93.1M -$1.5B -$47.21 -$608.7M -1627.6% —
FY2022 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

GRAIL, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

GRAIL, Inc. has historically struggled to out-earn its cost of capital, averaging just -52.9% ROIC.

GRAIL, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, GRAIL, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-369.03 per share.

GRAL stock: frequently asked questions

What is the intrinsic value of GRAIL, Inc. (GRAL) stock?

Graham's formula only works with positive earnings. GRAIL, Inc. reported diluted EPS of -$11.11 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does GRAIL, Inc. generate free cash flow?

GRAIL, Inc. generated -$299.9M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 3 reported years.

What is GRAL's return on invested capital?

Average ROIC over the last 4 fiscal years was -52.9%, and average return on equity was -48.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this GRAL data come from?

From GRAIL, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 6, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar medical laboratories stocks